Literature DB >> 26336079

Evaluation and correlation of the physicochemical properties of carvedilol.

Josyane Márcia Vasconcelos Alves1,2, Livia Deris Prado3, Helvécio Vinícius Antunes Rocha2,4.   

Abstract

Carvedilol is an antihypertensive drug with non-selective blockade (moderate selectivity for β1 and β2 adrenoceptors) and vasodilating properties due to α receptor blockade. Its molecule has one chiral centre; therefore, the drug has two enantiomers. Furthermore, it presents different polymorphs depending on the synthesis route and crystallization procedure. Carvedilol is a weak base that is substantially insoluble in water, acidic solutions, and gastric and intestinal fluids; it is classified as a Class II drug in the Biopharmaceutical Classification System. The solubility of carvedilol varies according to the solvent pH. This study aimed to evaluate and correlate the physicochemical and processability properties of carvedilol. Samples of the active ingredient from three different manufacturers were characterized according to their flowability, particle size and apparent density and using microscopy, differential scanning calorimetry (DSC), thermogravimetric analysis, X-ray diffraction, Fourier transform infrared spectroscopy, intrinsic dissolution and powder dissolution tests. It was determined that the tested samples presented the same polymorphic form, did not present good flowability, and presented different particle size distributions. The tests to evaluate flowability and compressibility were shown to be discriminative, and slight differences among the samples were noted.

Entities:  

Keywords:  Carvedilol; characterization; dissolution; flowability; polymorphism; raw material

Mesh:

Substances:

Year:  2015        PMID: 26336079     DOI: 10.3109/10837450.2015.1073740

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  3 in total

1.  Determination and Comparison of the Solubility, Oil-Water Partition Coefficient, Intestinal Absorption, and Biliary Excretion of Carvedilol Enantiomers.

Authors:  Qi Zhang; Xin Wang; Hongjiao Xue; Baolin Huang; Zimin Lin; Zheng Cai
Journal:  AAPS PharmSciTech       Date:  2021-01-10       Impact factor: 3.246

2.  A comprehensive map of disease networks and molecular drug discoveries for glaucoma.

Authors:  Haixin Wang; Yanhui Deng; Ling Wan; Lulin Huang
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

3.  Topography of Simulated Intestinal Equilibrium Solubility.

Authors:  Claire Dunn; Jeremy Perrier; Ibrahim Khadra; Clive G Wilson; Gavin W Halbert
Journal:  Mol Pharm       Date:  2019-04-16       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.